Most Recent
Aft goes on the offensive, files lawsuit over new Maxigesic ads
Competition & Consumer Protection 2019-02-26 2:04 pm By Cat Fredenburgh

AFT Pharmaceuticals has filed a lawsuit seeking to pre-empt competitor Reckitt Benckiser from pursuing a lawsuit against it over recent ads for its painkiller Maxigesic.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Ramsay Health denies anti-competitive conduct over failed day surgery
Competition & Consumer Protection 2019-02-25 9:17 pm By Miklos Bolza

Ramsay Health Care has denied its conduct towards a group of surgeons seeking to open a rival clinic in Coffs Harbour, NSW was anti-competitive or a misuse of market power, telling the court on the first day of trial that the venture was doomed to fail.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

‘Misconceived’ Sanofi appeal over injector pen patent gets shot down by Full Court
Intellectual Property 2019-02-25 1:34 pm By Cat Fredenburgh

The Full Court has denied a request by Sanofi that it review a judge’s refusal to block Alphapharm from listing its Semglee insulin injector pen on the PBS, calling the pharmaceutical giant’s appeal “misconceived”.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

ACCC intent on proving misuse of market power claims in Ramsay Health trial
Trials 2019-02-22 11:19 pm By Cat Fredenburgh

The stakes will be high for the ACCC when the trial kicks off Monday in its case against Ramsay Health Care alleging the hospital giant misused its market power and engaged in exclusive dealing, after the competition regulator came up short in its last big misuse of market power case against pharmaceutical giant Pfizer.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Fisher & Paykel, ResMed lay down swords in global patent dispute
Intellectual Property 2019-02-22 1:00 pm By Cat Fredenburgh

New Zealand-based medical device maker Fisher & Paykel and US-based ResMed have agreed to resolve all disputes between them over patents for devices used to treat sleep apnea.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Calgary CFO convicted for misstating company revenue
Healthcare 2019-02-20 10:20 pm By Cat Fredenburgh

The former chief financial officer for Calvary Health Care has been convicted and sentenced after pleading guilty to making false records that misstated the company’s revenue by millions of dollars.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Court to issue speedy ruling on Sanofi’s second stab at injector pen injunction
Intellectual Property 2019-02-20 9:48 pm By Cat Fredenburgh

The Full Federal Court will issue its judgment Friday in French pharmaceutical giant Sanofi’s challenge to a judge’s refusal to block Alphapharm from listing an insulin injector pen on the PBS, just two weeks after the court heard arguments in the appeal.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sandoz ordered to pay Lundbeck over $26.3M for infringing Lexapro patent
Intellectual Property 2019-02-19 10:18 pm By Christine Caulfield

Generic drug maker Sandoz must pay $26.34 million to Danish pharmacuetical giant Lundbeck and a subsidiary for infringing the Australian patent behind the blockbuster antidepressant Lexapro, a judge has found.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Neurim wins fight to amend patent for top-selling Circadin amid infringement case
Intellectual Property 2019-02-19 7:35 pm By Christine Caulfield

Drug maker Neurim Pharmaceuticals has won a bid to amend its Australian patent for top selling sleeping pill Circadin over the protests of two generic pharmaceutical companies, whch argued Neurim had purposely delayed the application to gain an unfair advantage in its infringement suit.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Allergan snips Botox trade mark case against Self Care
Intellectual Property 2019-02-18 9:17 pm By Miklos Bolza

Pharmaceutical giant Allergan has streamlined its trade mark case against Self Care Corporation, which makes products marketed as Botox alternatives.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?